Document is current
Any future updates will be listed below
-
Authors
Kienlein, Romana Maria
Trauzeddel, Ralf Felix
Akbari, Nilufar
Avalli, Leonello
Biancari, Fausto
Dini, Carlotta Sorini
Guenther, Sabina
Hagl, Christian
Heringlake, Matthias
Kruppa, Jochen
Mäkikallio, Timo
Martins, Raphael
de Chambrun, Marc Pineton
Rastan, Ardawan Julian
Rubino, Antonio
van den Brink, Floris
Nordine, Michael
Treskatsch, Sascha
-
Funding
Funding for this research was provided by:
Charité - Universitätsmedizin Berlin
- License Information
-
More Information
Article History
Received: 9 August 2024
Accepted: 6 January 2025
First Online: 17 January 2025
Declarations
:
: This meta-analysis was approved by the local ethics committee at Charité – Universitätsmedizin Berlin (EA4/239/19) as well as the local data protection authority. Consent to participate was not applicable.
: Not applicable.
: RFT, RMK, LA, CSD, RM, NA, JK, JAR, MN, MPdC, FB, TM, AR, FvdB have nothing to declare. SPWG received funding for the ECLS-SHOCK Trial (NCT02544594, Registration Date 02.09.2015) from the Sorin Group, Italy. MH reports honoraria for lectures and scientific advice by Orion Pharma, Amomed Pharma, Edwards Lifesciences, and CSL Behring. ST received funding for experimental research as well as honoraria for lectures from Edwards, OrionPharma, Amomed and Smith & Nephews outside this work.
